>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

March 18, 2014

FDA MedWatch - Merit Medical Systems, Custom Procedural Trays/Kits Containing 1 percent Lidocaine HCl Injection, 10mg/mL: Recall - Particulates Found in Hospira supplied Lidocaine

Summary:

Merit Medical Systems Custom Procedural Trays Kits Recall Particulates Found in Hospira Lidocaine

March 18, 2014

McKesson Technologies Anesthesia Care: Recall - Patient Case Data May Not Match Patient Data

Summary:

McKesson Technologies Anesthesia Care Recall Patient Case Data May Not Match Patient Data

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Testifies Before FDA on Safe Use of Propofol

ASA Immediate Past President Eugene P. Sinclair, M.D. testified before the FDA Advisory Committee on Anesthetic and Life Support Drugs on November 10, 2005. At issue was the petition filed by the American College of Gastroenterology to remove from the propofol (Diprivan®) labeling the following language:

“For general anesthesia or monitored anesthesia care (MAC) sedation, DIPRIVAN Injectable Emulsion should be administered only by persons trained in the administration of general anesthesia and not involved in the conduct of the surgical/diagnostic procedure.”

Dr. Sinclair was followed at the podium by anesthesiologists Carol Rose, M.D., of the University of Pittsburgh Medical Center, and until recently a member of the Advisory Committee, and Marc Koch, M.D., M.B.A., President and Chief Executive Officer of Somnia, Inc., a New York based Anesthesia Management Company, which specializes in providing comprehensive anesthesia, pain management and accreditation consulting services to office-based surgical facilities and ambulatory surgery centers throughout the United States. These three anesthesiologists were the only witnesses and they each testified in favor of keeping the warning on the propofol labeling.

Download a copy of Dr. Sinclair’s testimony and ASA’s letter commenting on the ACG petition filed with the FDA on October 19.